LILRB4 dysregulation boosts pro-inflammatory cytokine production, diminishes IL-10 levels in B cells, and regulates T- and B cell-mediated autoimmune diseases such as systemic lupus erythematosus34. This evidence concerns the gene LILRB4 and autoimmune disease.